Genome-wide association studies in Alzheimer's disease.
暂无分享,去创建一个
[1] B. Tycko,et al. Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer’s disease , 1996, Human Genetics.
[2] R. Tanzi,et al. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. , 2004, Neuron.
[3] Lon R Cardon,et al. Evaluating coverage of genome-wide association studies , 2006, Nature Genetics.
[4] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Tanzi,et al. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses , 2008, Nature Reviews Neuroscience.
[6] S. Fulda,et al. Thirty-eight-negative kinase 1 (TNK1) facilitates TNFα-induced apoptosis by blocking NF-κB activation , 2007, Oncogene.
[7] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[8] D. Campion,et al. Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update , 2005, Journal of Medical Genetics.
[9] Ronald C. Petersen,et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Alzheimer's & Dementia.
[10] Christoph Lange,et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.
[11] E. Matsubara,et al. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Tanzi,et al. Clearance of Alzheimer's Aβ Peptide The Many Roads to Perdition , 2004, Neuron.
[13] A. Diaspro,et al. Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor GRB2 and Modulate ERK 1,2 Signaling* , 2007, Journal of Biological Chemistry.
[14] E. Mufson,et al. Galanin Hyperinnervation Upregulates Choline Acetyltransferase Expression in Cholinergic Basal Forebrain Neurons in Alzheimer’s Disease , 2008, Neurodegenerative Diseases.
[15] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[16] S. Fulda,et al. Thirty-eight-negative kinase 1 (TNK1) facilitates TNFalpha-induced apoptosis by blocking NF-kappaB activation. , 2007, Oncogene.
[17] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.
[18] Eden R Martin,et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.
[19] S E Poduslo,et al. Genome screen of late‐onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[20] Andrew J. Saykin,et al. Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease , 2009, PloS one.
[21] M. Mitchell,et al. Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain , 2000, Mammalian Genome.
[22] Nick C Fox,et al. Early onset familial Alzheimer’s disease , 2002, Neurology.
[23] R. Kemler,et al. Presenilin-dependent processing and nuclear function of gamma-protocadherins. , 2005, The Journal of biological chemistry.
[24] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[25] Iuliana Ionita-Laza,et al. Genomewide weighted hypothesis testing in family-based association studies, with an application to a 100K scan. , 2007, American journal of human genetics.
[26] M. McCarthy,et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.
[27] John P. A. Ioannidis,et al. Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.
[28] Winnie S. Liang,et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. , 2007, Neuron.
[29] Deborah Blacker,et al. GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results. , 2009, Archives of neurology.
[30] S. Soond,et al. TRUSS, a tumor necrosis factor receptor‐1‐interacting protein, activates c‐Jun NH2‐terminal kinase and transcription factor AP‐1 , 2006, FEBS letters.
[31] M. Gill,et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.
[32] J. Hohmann,et al. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] Rappold,et al. Human Molecular Genetics , 1996, Nature Medicine.
[34] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[35] R. Kemler,et al. Presenilin-dependent Processing and Nuclear Function of γ-Protocadherins* , 2005, Journal of Biological Chemistry.
[36] Sven Cichon,et al. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling , 2008, BMC Medical Genomics.
[37] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[38] D. Jiang,et al. Cloning and characterization of a novel Krüppel-like zinc finger gene, ZNF268, expressed in early human embryo. , 2001, Biochimica et biophysica acta.
[39] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[40] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[41] M. Gilman,et al. Expression cloning of a novel zinc finger protein that binds to the c-fos serum response element , 1992, Molecular and cellular biology.
[42] S. Kauppinen,et al. Rhamnogalacturonan acetylesterase elucidates the structure and function of a new family of hydrolases. , 2000, Structure.